The United States represents a significant share of the Adefovir Dipivoxil Market, supported by the growing focus on the diagnosis and management of chronic hepatitis B. Rising awareness of liver health, increased screening among high-risk populations, and widespread availability of antiviral therapies are driving market demand. Strong healthcare infrastructure, favorable reimbursement...